Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Temelimab by GeNeuro for Unspecified Central Nervous System Disorders: Likelihood of Approval
Temelimab is under clinical development by GeNeuro and currently in Phase II for Unspecified Central Nervous System Disorders. According to...